Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation

Haematologica

Volumn 91, Issue 9, 2006, Pages 1268-1272

  Patriarca, Francesca ^a   Skert, Cristina ^b   Bonifazi, Francesca ^b   Sperotto, Alessandra ^b   Fili, Carla ^b   Stanzani, Marta ^b   Zaja, Francesco ^b   Cerno, Michela ^b   Geromin, Antonella ^b   Bandini, Giuseppe ^b   Baccarani, Michele ^b   Fanin, Renato ^b  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Late onset non infectious pulmonary complications; LONIPC; Stem cell transplantation; Survival

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; THALIDOMIDE;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DEATH; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; INCIDENCE; LUNG BIOPSY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RECURRENCE RISK; RESPIRATORY FAILURE; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGE OF ONSET; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; LUNG DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 33748764138     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest 1996;109:1066-77.
2. Palmas A, Tefferi A, Myers JL, Scott JP, Swensen SJ, Chen MG, et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998;100:680-7.
3. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295-304.
4. Shulman HM, Sullivan KM, Weiden PL, Mc Donald GB, striker GE, Sale GE, et al. Chronic graft-versus host syndrome in man: a long term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
5. ATS statement-Snowbird workshop on standardization of spirometry. Am Rev Respir Dis 1979;119:831-8.
6. Yoshihara S, Tateishi U, Ando T, Kunitoh H, Suyamara H, Onishi Y, et al. Lower incidence of bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant 2005;35:1195-200.
7. Patriarca F, Skert C, Sperotto A, Damiani D, Geromin A, Zaja F, et al. Incidence, outcome and risk factors of late-onset non-infectious pulmonary complications after unrelated donor stem cell transplantation. Bone Marrow Transplant 2004;33:751-8.
8. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989;111:368-76.
9. Schultz KR, Green GJ, Wensley D, Sargent MA, Magee JF, Spinell JJ, et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 1994;9:3212-20.
10. Duncker C, Dohr D, von Harsdorf S. Duyster J, Stefanic M, Martini C, et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome. Bone Marrow Transplant 2000;25:1263-8.
11. Chien JW, Martin PJ, Gooley TA. Flowers ME, Heckbet SR, Nichols G. et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003;168:208-14.
12. Freudenberger TD, Madtes DK, Curtis JR, Cummings P, Storer BE, Hackman RC. Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood 2003;102:3822-8.
13. Sakaida E, Nakaseko C, Hariam A, Yokota A, Cho R, Saito Y, et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation are significantly associated with chronic graft-versus-host disease and graft-versus-leukaemia effect. Blood 2003;102:4236-42.
14. Santo Tomas EH, Loberiza FR, Klein JP, Layde PM, Lipchik RJ, Rizzo JD, et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoieic stem cell transplantation for leukaemia. Chest 2005;128:153-61,
15. Fukuda T, Hackman RC, Guthrie KA, Sandmaier BM, Boeckh M, Maris MB, et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 2003;102:2777-85.
16. Ratanatharathorn V, Ayash L, Reynolds C, Silver S, Reddy P, Becker M, et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant 2003;9:505-11.
17. Rovelli A, Arrigo C, Nesi F, Nicolini B, Locasciulli A, Vassallo E, et al. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children. Bone Marrow Transplantation 1998;21:577-81.
18. Patel NR, Lee PS, Kim JH, Weinhouse GL, Koziel H. The influence of diagnostic bronchoscopy on clinical outcomes comparing adult autologous and allogeneic bone marrow transplant patients. Chest 2005;127:1388-96.
19. Zihlif M, Khanchandani G, Ahmed HP, Soubani AO. Surgical lung biopsy in patients with haematological malignancy or hematopoietic stem cell transplantation and unexplained pulmonary infiltrates: improved outcome with specific diagnosis. Am J Hematol 2005;78:94-9.